COVID-19 Pipeline Tracker

Find the latest updates on the efforts of the biotech industry around to globe

Here are some key takeaways:

  • In the fight against COVID-19, more than 400 unique drug programs were launched in just 16 weeks, including 101 experimental vaccines and 138 programs aimed directly at the SARS-CoV-2 virus;
  • Private-sector innovators are responsible for more than 90% of vaccines and therapeutics in development to protect individuals and communities from COVID-19;
  • More than 70% of COVID-19 R&D is being undertaken by small companies